5 Hypertension Clinical Trials in Jacksonville, NC (2026)

Q: How do I join a clinical trial in Jacksonville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you.

Recruiting Hypertension Studies in Jacksonville

NCT04071327Recruiting

Pulmonary Hypertension Association Registry

The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people...

Jacksonville, NC3,000 participantsPulmonary Hypertension Association, Inc.

View Study Details

NCT05983250Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....

Jacksonville, NC230 participantsTenax Therapeutics, Inc.

View Study Details

NCT07222917Recruiting

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safe...

Jacksonville, NC218 participantsAstraZeneca

View Study Details

NCT06797193Recruiting

Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension

This clinical trial tests the how well an ultrasound with subharmonic imaging and the subharmonic aided pressure estimation (SHAPE) technique works in identifying portal hypertension (PH). An ultrasou...

Jacksonville, NC60 participantsMayo Clinic

View Study Details

NCT07175038Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH). Each eligible parti...

Jacksonville, NC40 participantsAllRock Bio, Inc.

View Study Details

About Hypertension Clinical Trials in Jacksonville

Hypertension, or high blood pressure, is a common condition that increases the risk of heart disease, stroke, and kidney damage. Often called the "silent killer" because it usually has no symptoms. Management includes lifestyle modifications and medications to lower blood pressure.

There are currently 5 hypertension clinical trials recruiting participants in Jacksonville, NC. These studies are seeking a combined 3,548 participants. Research is being sponsored by Pulmonary Hypertension Association, Inc., Tenax Therapeutics, Inc., AstraZeneca and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hypertension Clinical Trials in Jacksonville — FAQ

Are there hypertension clinical trials in Jacksonville?

Yes, there are 5 hypertension clinical trials currently recruiting in Jacksonville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What hypertension treatments are being tested?

The 5 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for hypertension.

Data updated July 13, 2026 from ClinicalTrials.gov